P&G stock drops to 2.5-year low
April 26, 2018 at 11:49 AM EDT
Several factors likely contributed to the recent declining value of shares despite CEO David Taylor’s revelation last week that Procter & Gamble plans to pay $4.2 billion for German firm Merck KGaA’s consumer health business, which is expected to boost P&G’s annual revenue of $65 billion by about $1.1 billion.